Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Press Releases

Press Releases Home
          Inspections, Compliance, Enforcement, and Criminal Investigations
          Criminal Investigations
          Press Releases
          August 7, 2017: Notification of Stolen Sterile Prescription Injectable ProductsPress Releases August 7, 2017: Notification of Stolen Sterile Prescription Injectable Products
  
  	
    Share
    Post
    Linkedin

    Email
    PrintAuroMedics Pharma LLC (AuroMedics)is working with the U.S. Food and Drug Administration (FDA), and other law enforcement officials to recover three lots of sterile prescription injectable products. The trailer containing the products was stolen while en route to the Aurobindo Pharma Distribution Center in Dayton, NJ during July 27-28, 2017.The trailer was parked at a security yard in Elizabeth, NJ at the time of the theft.The stolen trailer contained two different AuroMedics products.The theft was immediately reported to the police. At the present time, the subject product has not been located.The impacted lots are listed in the table below.Product NameLot NumberExpiryMarket Units (Unit of Sale)TotalLevofloxacin in 5% Dextrose Injection 750mg/150mL BagCLF170020AMay 2019220 x 245280 bagsCLF170021AMay 2019477 x 2411448 bagsBupivicaine HCl Injection USP 0.5% 30mL VialCBU170091April 20191512 x 2537800 vialsAnyone who has information regarding this incident, or has received suspicious or unsolicited offers for the specified products after the date of the theft, is encouraged to contact the U.S. Food and Drug Administration’s (FDA) Office of Criminal Investigations (OCI) at 1-800-551-3989 or to visit the OCI Web Site (http://www.fda.gov/OCI).Additionally, individuals are also encouraged to immediately contact their local police with information as to how the above listed product was obtained.AuroMedicsadvises physicians, retailers, and consumers to check all products for signs of tampering or damage prior to use.  Do not use the product if the packaging appears to have been disturbed in any way.  It is always advisable to purchase product only from trusted and reliable sources and to be aware that an unusually low price may be an indication that the product may have been stolen.While AuroMedics is confident that the batches in question posed no health risk to the patient when they left our facility, AuroMedics urges any individuals who may be in possession of these batches of products to discontinue their use immediately and discard the product. This recommendation is solely due to the fact that, once the theft occurred, the batches were no longer within AuroMedics control; therefore, we are unaware of the conditions under which the batches were stored.Healthcare professionals and patients who may be in possession of these batches are encouraged to report any adverse events, side effects, or product quality problems related to the use of these batches to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:·Complete and submit the report Online:www.fda.gov/MedWatch/report.htm·Download formor call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178Alternatively, healthcare professionals and patients may contact the AuroMedics Pharmacovigilance department toll-free at 1-888-238-7880 – prompt #2.We thank you for your cooperation.

                                                                                  Content current as of:
      01/24/2018Press Releases
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop